Samjin Pharmaceutical Ltd.

Samjin Pharmaceuticals, Seoul-based, sells OTC drugs like Gevorin and Trestan while driving a pipeline with phase‑II SA001 for dry eye, phase‑I SJP1804 for macular degeneration, and oncology candidates SJP1604, SJP1901/1902—offering growth potential.

Headquarters: South Korea (KOR)

Samjin Pharmaceutical Ltd. Logo
Company Profile
  • Employees: 586
  • HQ: Seoul
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
005500 Samjin Pharmaceutical Ltd.
Cap: 241.6B
EQUITY KSC KRW KR7005500004 Active
📈
Home Login